Nuveen LLC’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.7M Buy
3,534,454
+2,110,808
+148% +$18.9M 0.01% 826
2025
Q1
$17.2M Buy
+1,423,646
New +$17.2M 0.01% 1213